Immix Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMMX and other ETFs, options, and stocks.

About IMMX

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA. 

CEO
Ilya Rachman
CEOIlya Rachman
Employees
21
Employees21
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
2012
Founded2012
Employees
21
Employees21

IMMX Key Statistics

Market cap
308.73M
Market cap308.73M
Price-Earnings ratio
-7.42
Price-Earnings ratio-7.42
Dividend yield
Dividend yield
Average volume
971.74K
Average volume971.74K
High today
$6.20
High today$6.20
Low today
$5.75
Low today$5.75
Open price
$5.87
Open price$5.87
Volume
864.75K
Volume864.75K
52 Week high
$7.73
52 Week high$7.73
52 Week low
$1.34
52 Week low$1.34

Stock Snapshot

Immix Biopharma(IMMX) stock is priced at $5.83, giving the company a market capitalization of 308.73M. It carries a P/E multiple of -7.42.

On 2026-02-02, Immix Biopharma(IMMX) stock traded between a low of $5.75 and a high of $6.20. Shares are currently priced at $5.83, which is +1.4% above the low and -6.0% below the high.

Immix Biopharma(IMMX) shares are trading with a volume of 864.75K, against a daily average of 971.74K.

During the past year, Immix Biopharma(IMMX) stock moved between $1.34 at its lowest and $7.73 at its peak.

During the past year, Immix Biopharma(IMMX) stock moved between $1.34 at its lowest and $7.73 at its peak.

People also own

Based on the portfolios of people who own IMMX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.